Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy (Q35601592)

9 August 2017

1 reference

title

Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy (English)

1 reference

9 August 2017

Stephan Braun

1

1 reference

9 August 2017

Florian D Vogl

2

1 reference

9 August 2017

Wolfgang Janni

3

1 reference

9 August 2017

Christian Marth

4

1 reference

9 August 2017

Günter Schlimok

5

1 reference

9 August 2017

Klaus Pantel

6

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

12

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

397-404

1 reference

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Combined transcriptome and genome analysis of single micrometastatic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Comparative analyses of bone marrow micrometastases in breast and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

The Relationship Between Micrometastases in the Bone Marrow, Histopathologic Features of the Primary Tumor in Breast Cancer and Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Monoclonal Antibodies Detect Occult Breast Carcinoma Metastases in the Bone Marrow of Patients with Early Stage Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Rationale for adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Antibody-based immunological therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Antibodies as cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Delivery of molecular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Cancer genes: complexes and complexities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

Detection and measurement of occult disease for the prognosis of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900143-7

7 January 2021

10.1016/S0960-9776(03)00143-7

Identifiers

DOI

1 reference

release_iedtecuunzeifbf2hokm66iapm

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iedtecuunzeifbf2hokm66iapm

24 November 2022

mapped directly with Wikidata item

1 reference